Bone Marrow Failure Syndromes Completed Phase 2 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

Also known as: Bone Marrow Failure Syndrome / Bone Marrow Failure Disorders

IndicationStatusPhase
DBCOND0035172 (Bone Marrow Failure Syndromes)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02224872Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic AnemiaTreatment